PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
20 hedge funds and large institutions have $21.7M invested in PLx Pharma Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
43% more funds holding
Funds holding: 14 → 20 (+6)
23% more capital invested
Capital invested by funds: $17.7M → $21.7M (+$4.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$351K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$315K |
| 3 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$285K |
| 4 |
SIM
Spark Investment Management
New York
|
+$241K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$880K |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$227K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.12K |
PLXP Hedge Fund Activity: Q1 2015 in Review
20 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q1 2015, worth a combined $21.7M — up 23% from $17.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PLXP positions and 1 closed out — a net gain of 6 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Pacific Alternative Asset Management Company (PAAMCO), opening a new position worth an estimated $351K. The largest seller was Pine River Capital Management, exiting entirely with an estimated $880K sold.
- 20 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q1 2015, up from 14 in Q4 2014.
- Funds reported $21.7M of PLx Pharma Inc. Common Stock stock for Q1 2015, up 23% quarter-over-quarter.
- 7 funds opened new PLx Pharma Inc. Common Stock positions in Q1 2015 and 1 closed out, a net change of +6 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q1 2015 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $351K added.
- The largest PLx Pharma Inc. Common Stock seller in Q1 2015 was Pine River Capital Management, an estimated $880K sold.
Based on aggregated 13F filings for Q1 2015.